
Blood draw
Syphilis including titer determination
Serology including titer; for syphilis diagnostics.
€ 51,00
Your privacy
Necessary cookies keep the website working.
With your consent, we use additional cookies to:
We may share visited pages, interactions and device data with 5 service providers.
Hashed contact details are shared only with marketing consent.
You can change this later through Cookie preferences at the bottom of every page.
More information is available in our privacy policy.
STIs · Blood
Titer measurement of antibodies against the syphilis bacterium; usually stays positive for life after a treated syphilis.
At a glance
TPHA titer (syphilis)
Explanation
Syphilis is an STI caused by the bacterium Treponema pallidum. The TPHA (Treponema pallidum hemagglutination assay) looks for antibodies aimed specifically at this bacterium. For a titer measurement, the laboratory dilutes the blood step by step and checks up to which dilution the antibodies are still detectable; the result is a ratio such as 1:80 or 1:1280. According to the LCI guideline (RIVM), these antibodies usually remain detectable for life, even after proper treatment. Whether an infection is active is shown by a different test, the RPR.
Result
A positive result means that antibodies against the syphilis bacterium have been found. This may fit an active syphilis, a previously treated syphilis or, less often, a false positive result. According to the LCI guideline (RIVM), the height of the titer says little about whether the infection is active or needs treatment; that requires a confirmation test and an RPR test. Antibodies against related tropical bacteria, such as yaws, can also make the test positive. Without treatment, syphilis does not go away on its own and can damage the brain, eyes, heart and blood vessels after years, but it can be treated well with antibiotics.
A negative result means that no antibodies against the syphilis bacterium have been found. Shortly after infection, antibodies are often not yet detectable. If early syphilis is suspected, such as a painless sore after sex, the LCI guideline (RIVM) advises repeating the blood test after 3, 6 and 12 weeks; with a sore, a test on the wound fluid (PCR) detects the bacterium itself. After using antibiotics shortly after the infection, the test can stay negative for longer or permanently.
With a positive result, a confirmation test and an RPR test follow, and testing for HIV and other STIs is also done. With an active syphilis, treatment with antibiotics follows and sexual partners are informed, tested and treated if needed. Syphilis is not notifiable for individual cases.
Reliability
The TPHA is a treponemal test: the antibodies are specific to the syphilis bacterium and, according to the LCI guideline (RIVM), usually remain detectable for life, even after proper treatment. A positive result is not a diagnosis on its own; the guideline names a confirmation test (IgG immunoblot) and an RPR test as the next step. According to the guideline, the TPHA titer usually gives no extra insight and is not suitable for monitoring the effect of treatment; the RPR titer, by contrast, does fall after successful treatment.
Who it is for
The result is most meaningful after sex without a condom with a new or changing partner, for men who have sex with men, sex workers and people with HIV, if a partner has syphilis, and with symptoms such as a painless sore on or around the penis, vagina, anus or mouth, or a non-itchy skin rash. For people who have had syphilis before, this test says nothing about a new infection; an RPR titer then says more.
In 2024, syphilis was diagnosed in 1,798 people at the Sexual Health Centers; 92 percent of them were men who had sex with men. Syphilis is also more common in people with HIV. Almost no babies with syphilis are born in the Netherlands, because all pregnant women are screened.
The RIVM (Sexual Health Centers, 2024)
Evidence
This explanation is based on Dutch guidelines and independent information. It is general information, not a diagnosis. Discuss an abnormal result with your GP.
More about risks and resultsMore explanations